Rationale, design and population baseline characteristics of the PERFORM Vascular Project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) trial

Author： Hennerici Michael   Bots Michiel   Ford Ian   Laurent Stéphane   Touboul Pierre  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.24, Iss.2, 2010-04, pp. : 175-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The risk of stroke within a week of minor stroke or transient ischemic attack

By Sanossian Nerses   Ovbiagele Bruce  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2069-2076

Informa Healthcare

Access to resources Recommend Favorite

Stenting and Prevention of Ischemic Stroke

By  

Current Drug Targets, Vol. 8, Iss. 7, 2007-07 ,pp. : 867-873

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention of Ischemic Stroke: Surgery

By  

Current Drug Targets, Vol. 8, Iss. 7, 2007-07 ,pp. : 860-866

Bentham Science Publishers

Access to resources Recommend Favorite

Secondary Prevention of Ischemic Stroke

By  

Current Drug Targets, Vol. 5, Iss. 5, 2004-07 ,pp. : 457-472

Bentham Science Publishers

Access to resources Recommend Favorite

Acute Ischemic Cerebrovascular Events on Antiplatelet Therapy: What is the Optimal Prevention Strategy?

By  

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3788-3794

Bentham Science Publishers

Access to resources Recommend Favorite